In conclusion, the study proposed that LETM2 may facilitate tumor development by promoting the PI3K-Akt signaling pathway in PDAC, which provides prospective targets for the diagnosis, treatment, and prognosis of PDAC. This evidence concerns the gene AKT1 and neoplasm.